Brachial Artery Flow-Mediated Dilation and Asymmetrical Dimethylarginine in the Cardiovascular Risk in Young Finns Study

Authors:
  • JVJorma S.A. Viikari
    Jorma S.A. Viikari
  • GAGeorg Alfthan
    Georg Alfthan
  • JMJukka Marniemi
    Jukka Marniemi
  • MKMika KähÖnEn
    Mika KähÖnEn
  • LTLeena Taittonen
    Leena Taittonen
  • TLTomi Laitinen
    Tomi Laitinen
  • OROlli T. Raitakari
    Olli T. Raitakari
Publisher website
Google Scholar
Abstract
Background— Elevated asymmetrical dimethylarginine (ADMA) is a novel risk factor for atherosclerosis that may impair endothelial function by interfering with endothelial nitric oxide synthesis. To gain insight into the effects of ADMA on systemic endothelial function, we examined the association between ADMA and brachial artery flow-mediated dilation (FMD) in a large population of young adults. Methods and Results— Plasma ADMA and brachial FMD, as well as conventional cardiovascular risk factors, were measured in 2096 white adults aged 24 to 39 years. In univariate analysis, ADMA was inversely correlated with FMD ( r =−0.07, P =0.003). The inverse association between ADMA and FMD remained significant in a multivariable regression model adjusted for age, sex, conventional cardiovascular risk factors, estimated glomerular filtration rate, and brachial artery baseline diameter (β±SE −1.56±0.62%, P =0.01). Conclusions— We conclude that elevated plasma ADMA concentrations are associated with decreased brachial FMD responses in healthy adults. These data provide evidence at the population level that ADMA levels are associated with endothelial function.

This publication has 42 references indexed in Scilit: